Crypto EcoBlog
The price of Pfizer stocks fell 4% down to $38.51 during Q4 2019. During the last year, the company bought back approximately $9 billion in its stocks to foster market growth. However, the largest medicine giant is losing money and wants its Upjohn development to merge with Mylan NV, which is another big drugmaker aiming at new types of medications.The Upjohn is selling the drugs that lost patent protection, such as Viagra and Lyrica. By the middle of 2020, the company management will...
Read More »